Maria Pilar D. M.
- Country
- Spain
- Department
- Neurology
Research Overview
- Evaluation of the Safety and Efficacy of Subcutaneous Tertomotide (GV1001) in Mild to Moderate Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Mirodenafil Dihydrochloride in Early Alzheimer's Disease: A Phase 3 Double-Blind, Randomized, Placebo-Controlled Trial
- Efficacy, Safety, and Tolerability of Bepranemab in Prodromal to Mild Alzheimer's Disease: A Placebo-Controlled Study with Open-Label Extension
Data & Insights
Has run more than one trial at 50 of 145 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in early-stage Alzheimer's Disease, with particular emphasis on developing therapeutic interventions for cognitive decline. Their research focuses on evaluating novel treatment approaches targeting the underlying mechanisms of neurodegeneration.
- Early Alzheimer's Disease Management
- Cognitive Function Assessment
- Disease Progression Monitoring
The investigator utilizes advanced clinical assessment tools including the Clinical Dementia Rating Scale to evaluate therapeutic outcomes.
Therapeutic Innovation
Their research encompasses the evaluation of monoclonal antibody therapies in neurodegenerative conditions. The investigator's work includes assessment of novel compounds targeting specific pathological proteins in Alzheimer's Disease.
- Antibody-Based Therapeutics
- Tau Protein Targeting
- Novel Treatment Approaches
A key focus lies in investigating innovative therapeutic agents for addressing the pathological processes of neurodegeneration.
Clinical Assessment
The investigator specializes in cognitive and functional assessment methodologies for early-stage neurological conditions. Their expertise includes comprehensive evaluation of treatment effects on daily living activities and cognitive performance.
- Cognitive Function Monitoring
- Treatment Response Assessment
- Long-term Outcome Evaluation
Expertise extends to measuring therapeutic efficacy through standardized clinical assessment tools.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.